What is Vincristine?

Category: Prescription Drugs


See also: CALGB 9251 Doxorubicin liposomal-vincristine-dexamethasone (DVD) EPOCH R-CVP protocol Vincristine-doxorubicin-dexamethasone (VAD)

Vincristine is an antineoplatic agent used in the treatment of leukemias, Hodgkin's disease, non-Hodgkin's lymphomas, Wilms' tumor, neuroblastoma, rhabdomyosarcoma. It is used in combination with other agents in regimens for multiple myeloma.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 1
Mild 1
None 0

Commonly reported side effects and conditions associated with Vincristine

Side effect Patients
Hair loss 1
Leukopenia 1
Nausea 1
Numbness in hands 1
Tiredness 1
Unintentional weight loss 1

Why patients stopped taking Vincristine

Multiple reasons could be selected

Reason Patients
Course of treatment ended 2
Doctor's advice 2
Side effects too severe 2
Did not seem to work 1
See all 3 patients who've stopped taking Vincristine


Stopped taking Vincristine

Duration Patients
Less than 1 month 2
1 - 6 months 1
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 1
$25-49 0
< $25 1
Not specified 0
Last updated:
There are no evaluations for Vincristine.